Polar Asset Management Partners Inc. Erasca, Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Erasca, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 200,300 shares of ERAS stock, worth $562,843. This represents 0.02% of its overall portfolio holdings.
Number of Shares
200,300
Previous 263,500
23.98%
Holding current value
$562,843
Previous $621,000
12.08%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ERAS
# of Institutions
142Shares Held
225MCall Options Held
28.7KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$54.5 Million2.85% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.8MShares$47.3 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$45.6 Million4.58% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$38.7 Million1.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$37.3 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $343M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...